Microbial Distribution and Antibiotic Susceptibility of Bloodstream Infections in Different Intensive Care Units

Background: Bloodstream infection (BSI) is an increasing public health concern worldwide, representing a serious infection with significant morbidity and mortality, especially in children and the elderly. The predominant microbial distribution and antibiotic susceptibility were investigated among BSIs in the different intensive care units (ICUs)—pediatric ICU (PICU), surgical ICU (SICU), cardiac ICU (CICU), respiratory ICU (RICU), and geriatric ICU (GICU)—in order to achieve more efficient and appropriate therapies for patients in various ICUs.

Methods: In this retrospective cross-sectional study, the blood specimens were collected from five different ICUs of Peking University First Hospital and comprehensive ICU of Miyun Teaching Hospital (Miyun ICU) before antimicrobial treatment from 2017 to 2020. Microorganism cultures of the blood samples were conducted, and positive cultures were tested for type of pathogens and drug susceptibility.

Results: The prevalence of BSIs was the highest in the Miyun ICU (10.85%), followed by the RICU (9.48%) and the PICU (8.36%). The total prevalence of Gram-positive bacterial strains (especially Staphylococcus spp. and Enterococcus spp.) in the PICU (44.55%), SICU (57.58%), CICU (55.00%), GICU (49.06%), and Miyun ICU (57.58%) was higher than that of Gram-negative bacteria. The major bacterial strain was Acinetobacter baumannii in the PICU (21.82%); Klebsiella pneumoniae in the SICU (12.88%), CICU (30.00%), and RICU (30.39%); Escherichia coli in the GICU (20.75%); and Staphylococcus epidermidis (18.18%) in the Miyun ICU. Staphylococcus hominis of BSIs remained highly susceptible (>70%) to gentamicin, linezolid, daptomycin, teicoplanin, vancomycin, tigecycline, and rifampicin in all the ICUs. Its antibiotic sensitivity to levofloxacin was moderate in the PICU and CICU, but mild (<30%) in the SICU, RICU, and GICU. K. pneumoniae was highly susceptible to doxycycline, minocycline, and tigecycline in all the ICUs except the RICU, and its antibiotic sensitivity to imipenem, meropenem, amikacin, ciprofloxacin, and levofloxacin was high/moderate in the PICU, CICU, GICU, and Miyun ICU, but mild in the SICU and RICU.

Conclusion: The current study demonstrated the distribution of prevalent microorganisms, and their antimicrobial susceptibility exhibited a high divergence among BSIs in different ICUs from a tertiary hospital and an outer suburban hospital in Beijing. Therefore, different antibiotic therapies for various wards and distinct age groups (especially between pediatric and elderly patients) should be considered to control the emergence and spread of highly antibiotic-resistant infections.

Background

Bloodstream infection (BSI), a serious infection with significant morbidity and mortality, becomes an increasing public health concern worldwide. Population-based studies in North America and Europe demonstrate that the BSI incidence ranged between 113 and 204 per 100,000 population (Goto and Al-Hasan, 2013; Kern and Rieg, 2020). A previous research based on the Swiss antibiotic resistance surveillance system (ANRESIS) described temporal trends and revealed a rise in the incidence rate of BSIs (increased by 14%, from 211 in 2008 to 240 per 100,000 population in 2014), especially among elderly patients (≥65 years) (Buetti et al., 2017). Moreover, it is also reported that BSIs remained one of the leading causes of death with an overall estimated fatality rate of 12.7% in the pediatric population (Droz et al., 2019). Antimicrobial agents are commonly administered to treat BSIs, but the clinical management is not so effective because of antibiotic resistance.

In recent years, the rise in multidrug-resistant pathogens is one of the most serious global public health threats, and the World Health Organization (WHO) has published the first global report on surveillance of antimicrobial resistance, showing the extent of this phenomenon in many parts of the world (World Health Organization., 2014). Empirical therapeutics is often started immediately in suspected BSI to reduce associated morbidity and mortality because of the routine delays in receiving blood culture and antibiotic susceptibility analysis. However, the current international guidelines are not suitable for all regions and generic recommended antimicrobial therapy is sometimes not adapted to local susceptibility patterns in developing countries (Penno et al., 2015; Labi et al., 2016). Changing antimicrobial resistance rates, pathogen distribution, demographics, and medical care delivery all may affect the epidemiology of BSI. Therefore, updated trends in the microbiology of BSI pathogens and the antibiotic susceptibility are required to support therapeutic guidelines for appropriate therapies.

The effective selection and use of antibiotics lately has become a huge challenge for all physicians. However, a comparison of relative frequency and microbiological characteristics of the pathogens in patients with BSIs in different intensive care units (ICU) was seldom investigated thoroughly in China, particularly in elderly (>60 years) and pediatric patients. In the this study, the microbial distribution and antibiotic sensitivity of BSIs in the pediatric ICU (PICU), surgical ICU (SICU), cardiac ICU (CICU), respiratory ICU (RICU), and geriatric ICU (GICU) from a tertiary hospital and the comprehensive ICU from an outer suburban hospital were investigated to achieve more efficient treatment protocols and better recovery in the hospital.

Materials and Methods

Subjects

We conducted a cross-sectional study with a retrospective cohort in the Department of PICU, Department of SICU, Department of CICU, Department of RICU, and Department of GICU in Peking University First Hospital (PKUFH, a large-scale tertiary hospital in Beijing), and Department of Comprehensive ICU in Miyun Teaching Hospital (a small-scale hospital located on the outer suburb of Beijing) (Miyun ICU) from January 1, 2017, to June 30, 2020. Five hundred sixteen positive culture samples from 6,597 blood samples in the PICU, SICU, CICU, RICU, and GICU of PKUFH and 275 positive cultures from 2,534 blood specimens in the Miyun ICU were analyzed (Table 1). The blood samples were collected before antimicrobial treatment. BSIs are defined by the presence of an organism within the bloodstream with or without signs or symptoms of an infection (Watson and Al-Hasan, 2014). The clinical clues were also taken into account for BSI validation; for example, the number of white blood cells, value of C-reactive protein and procalcitonin, and clinical signs of infection such as a fever and chills. This study has been reviewed and approved by the Institutional Ethics Committee of Peking University First Hospital and Miyun Teaching Hospital, and a review in terms of patient consent was not needed because of the retrospective observational design according to the committee decision.

TABLE 1

Table 1. Blood cultures of patients in different intensive care units.

Microorganism Identification and Drug-Susceptibility Test

Microorganism cultures were conducted according to the routine standard operation procedure (SOP) described previously (Duan et al., 2020): blood specimen was inoculated into a commercial culture bottle and analyzed by an automated monitoring system for bacterial detection (BD BACTEC™, BD, San Jose, CA, United States). The incubation was continued until a positive culture was observed or up to a maximum of 5 days. Positive bacterial cultures from patients’ blood samples collected within the first 24 h of admission were tested for type of pathogens and sensitivity to antibiotics. The microorganisms were identified to species level by standard biochemical methods including matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) (Bruker Daltonics, Billerica, MA, United States) and automated methods using the VITEK system (bioMérieux, Marcy-l’Étoile, France). The bacterial isolates were tested for antimicrobial susceptibility by VITEK 2 Compact (bioMérieux, France) or the manual Kirby–Bauer (K–B) disk diffusion method. Interpretations of drug susceptibility data were based on the Clinical Laboratory Standards Institute (CLSI, United States) standard.

Statistical Analysis

Continuous values of ages are expressed as mean ± SD. Microbial distribution and antibiotic susceptibility data were presented as percentages. Descriptive statistical analysis of the quantile–quantile plot (Q–Q plot) was used to determine the normality of demographic data of patient, and the chi-square (χ²) test was performed to compare differences in microbial distribution among different ICUs using SPSS version 16.0 software (SPSS Inc., Chicago, IL, United States). A p < 0.05 was considered statistically significant.

Results

Prevalence of Positive Blood Cultures in Different Intensive Care Units

From January 1, 2017, to June 30, 2020, the frequencies of reportedly positive cultures were 110 out of 1,316 blood samples in the PICU; 132 out of 2,160 in the SICU; 40 out of 541 in the CICU; 181 out of 1,909 in the RICU; 53 out of 671 in the GICU; and 275 out of 2,534 in the Miyun ICU (Figure 1). The blood sample collection covers the first half of 2020 when COVID-19 emerged and spread. The number of patients or hospital admission rates might be reflected on the changes in the amounts of samples sent to our laboratories. It was found that the lowest amount of blood samples was collected in the five ICUs of PKUFH in 2020, relative to the first half of the other 3 years (Figure 2). However, the amount of blood specimens of Miyun ICU did not change much. The prevalence of positive blood cultures of the patients in different ICUs is summarized in Table 1. The prevalence of positive blood cultures of Miyun ICU was significantly higher than that in five ICUs of PKUFH (10.85% vs. 7.82%, p < 0.05). Among the five ICUs of PKUFH, the RICU had the highest prevalence of BSIs (9.48%), followed by the PICU (8.36%), and SICU had the lowest one (6.11%) (p < 0.05). The major resistance patterns of bacterial pathogens were methicillin-resistant coagulase-negative Staphylococcus (MRCNS) (21.82%) and carbapenem-resistant Acinetobacter baumannii (CRAB) (19.09%) in the PICU; MRCNS in the SICU (27.27%), CICU (25.00%), GICU (20.75%), and Miyun ICU (36.00%); and MRCNS (27.07%) and carbapenem-resistant Enterobacteriaceae (CRE) (27.07%) in the RICU.

FIGURE 1

Figure 1. Distribution of microorganisms of bloodstream infections patients from different intensive care units (ICU). Gram-positive bacteria remained the major pathogens among the blood cultures except the respiratory intensive care unit (RICU).

FIGURE 2

Figure 2. The blood sample collection covers the first half of 2020 when COVID-19 emerged and spread during this period. The lowest amount of blood samples was collected in the five ICUs of PKUFH in 2020, relative to the first half of the other 3 years. The amount of blood specimens of Miyun ICU did not change much in 2020.

Distribution and Comparison of Microorganisms in Blood Cultures

The profile of microorganisms isolated from BSI patients is summarized in Figure 1. In the PICU, the most common bacterial strains in blood samples were Acinetobacter baumannii (A. baumannii) (n = 24, 21.82%) and Staphylococcus epidermidis (S. epidermidis) (n = 13, 11.82%), followed by Enterococcus faecalis (E. faecalis) (n = 9, 8.18%) and Staphylococcus hominis (S. hominis) (n = 8, 7.27%). In the SICU, the four most frequent pathogens were Klebsiella pneumoniae (K. pneumoniae) (n = 17, 12.88%), E. faecalis (n = 16, 12.12%), S. hominis (n = 12, 9.09%), and S. epidermidis (n = 10, 7.58%) among blood cultures. Gram-positive bacteria (n = 22, 55.00%) accounted for over 50% in blood specimens of patients admitted to the CICU, but Gram-negative K. pneumoniae (n = 12, 30.00%) was the dominant microorganism. Staphylococcus aureus (S. aureus) (n = 8, 20.00%) was the second most common bacterium, followed by S. hominis (n = 5, 12.50%) and S. epidermidis (n = 4, 10.00%). In the RICU, Gram-negative bacteria (n = 76, 41.99%) remained the major pathogens of patients’ blood cultures, and the five most frequent bacterial strains were K. pneumoniae (n = 55, 30.39%), S. hominis (n = 16, 8.84%), S. epidermidis (n = 13, 7.18%), Staphylococcus capitis (S. capitis) (n = 11, 6.08%), and A. baumannii (n = 10, 5.52%). The most predominant microorganism in the GICU was Escherichia coli (E. coli) (n = 11) with an isolation rate of 20.75%, followed by K. pneumoniae (n = 10, 18.87%), S. hominis (n = 7, 13.21%), and Enterococcus faecium (E. faecium) (n = 7, 13.21%). In the Miyun ICU, the most common bacterial strains in blood samples were S. epidermidis (n = 50, 18.18%), followed by E. faecium (n = 37, 13.45%), K. pneumoniae (n = 23, 8.36%), E. coli (n = 23, 8.36%), and S. hominis (n = 22, 8.00%).

Among the blood cultures, the frequency of Gram-positive bacterial strains (especially Staphylococcus spp. and Enterococcus spp.) was higher than that of Gram-negative bacterial strains in the PICU (n = 49, 44.55%), SICU (n = 76, 57.58%), CICU (n = 22, 55.00%), GICU (n = 26, 49.06%), and Miyun ICU (n = 76, 57.58%), of which, however, Gram-negative A. baumannii, K. pneumoniae, and E. coli were the most prevalent. In addition, K. pneumoniae was the dominant pathogen in three of the five ICUs of PKUFH (such as the SICU, CICU, and RICU). Fungal pathogens in the PICU, SICU, CICU, RICU, GICU, and Miyun ICU were, respectively, at 23.64, 8.33, 2.50, 19.34, 5.66, and 6.91%, and Candida albicans and Candida parapsilosis were the most common fungi.

Antibiotic Susceptibility of Major Bacteria of Bloodstream Infections

The drug susceptibility of Gram-positive S. hominis and E. faecium was selected, as shown in Table 2 and Figure 3. As the predominant Gram-positive bacterium, S. hominis remained highly susceptible (>70%) to gentamicin, linezolid, daptomycin, teicoplanin, vancomycin, tigecycline, and rifampicin in all the ICUs, moderately susceptible (30–70%) to clindamycin apart from the GICU. Its antibiotic sensitivity to levofloxacin was moderate in the PICU and CICU, but mild (<30%) in the SICU, RICU, and GICU. E. faecium exhibited high sensitivity to linezolid and tigecycline and mild sensitivity to benzylpenicillin and erythromycin in all the ICUs, and it was highly sensitive to teicoplanin and vancomycin in the PICU, SICU, GICU (except RICU and CICU), and Miyun ICU. Its drug susceptibility to ampicillin and gentamicin was moderate in PICU and mild in other ICUs.

TABLE 2

Table 2. Drug-susceptibility of major Gram-positive bacteria of bloodstream infections in different intensive care units (%).

FIGURE 3

Figure 3. Major Gram-positive bacteria isolated and their drug-susceptibility rates in patients with bloodstream infections from different intensive care units (ICU). The antimicrobial susceptibility performed by VITEK 2 Compact or the manual Kirby–Bauer (K–B) disk diffusion method.

The antibiotic sensitivity of Gram-negative K. pneumoniae, E. coli, and A. baumannii was selected, as shown in Table 3 and Figure 4. K. pneumoniae of BSIs remained highly sensitive to doxycycline, minocycline, and tigecycline in all the ICUs of PKUFH except RICU and moderately susceptible to piperacillin/tazobactam, ceftazidime, cefoperazone/sulbactam, and cefepime in the PICU, CICU, and GICU. Its antibiotic sensitivity to imipenem, meropenem, and amikacin was high in PICU, CICU, and GICU, moderate in the Miyun ICU, and mild in the SICU and RICU. Moreover, the susceptibility to ciprofloxacin and levofloxacin was high in the PICU and CICU, moderate in the GICU and the Miyun ICU, and still mild in the SICU and RICU. E. coli was highly susceptible to the tested antibiotics in the CICU and highly susceptible to meropenem, imipenem, ceftazidime, and piperacillin/tazobactam in the SICU, GICU, and Miyun ICU, whereas it exhibited moderate or relatively low drug susceptibility to other antibiotics except doxycycline, minocycline, and tigecycline in the PICU, SICU, and GICU. A. baumannii was highly sensitive to tigecycline and mildly sensitive to piperacillin/tazobactam, cefoperazone/sulbactam, imipenem, meropenem, and ciprofloxacin in the ICUs. Moreover, its susceptibility to ceftazidime, cefepime, tobramycin, levofloxacin, doxycycline, and minocycline was moderate in PICU, but mild in the SICU and RICU.

TABLE 3

Table 3. Drug susceptibility of major Gram-negative bacteria of bloodstream infections in different intensive care units (%).

FIGURE 4

Figure 4. Major Gram-negative bacteria isolated and their drug-susceptibility rates in patients with bloodstream infections from different intensive care units (ICU). The antimicrobial susceptibility performed by VITEK 2 Compact or the manual Kirby–Bauer (K–B) disk diffusion method.

Discussion

In the present study, we carried out a retrospective cross-sectional study from January 1, 2017, to June 30, 2020, in the Department of PICU, SICU, CICU, RICU, and GICU in Peking University First Hospital and Department of Comprehensive ICU in Miyun Teaching Hospital to analyze the positive blood cultures isolated from patients with BSIs. It was demonstrated that the microbial distribution and antibiotic susceptibility exhibited a high divergence among BSIs in different ICUs. Therefore, different antibiotic therapies for various wards and distinct age groups were suggested to prevent highly antibiotic-resistant infections, especially in the RICU and GICU.

Bloodstream infections comprise a wide variety of pathogens and clinical syndromes with quite diverse risk factors, therapeutic implications, and outcomes. The infections occur when one or more pathogens invade the bloodstream, usually causing a systemic inflammatory response syndrome (SIRS; Del Bono and Giacobbe, 2016). BSIs were defined as the isolation of pathogenic organisms from at least one blood culture sample. The detection of the causing pathogen by using molecular techniques has been proven suboptimal, and blood culture remains the gold standard and first-line tool in the pathogen diagnostics of BSIs and sepsis (Rhodes et al., 2017). Microbiological cultures of blood specimens provided clinically relevant information concerning the identity and analysis of microorganisms with their susceptibility to antibiotics. The prevalence of positive blood cultures of Miyun Teaching Hospital comprehensive ICU was the highest (10.85%) among all the ICUs, which indicated that the infection control and treatment might need to be improved in this outer suburban hospital. In Peking University First Hospital, we found that blood specimens of the RICU had the highest positive frequency (9.48%), similar to the finding in an Indian tertiary care institute where SIRS-related sepsis and BSI were 11.5% in the RICU (Agarwal et al., 2006). Previous studies observed a percentage of positive blood culture from 7 to 9.89% in children (Deen et al., 2012; Le Doare et al., 2015), and the presence of BSIs was also relatively high (8.36%) in the PICU, probably due to the immature state of children’s immune system predisposing them to infections.

This study was carried out from January 1, 2017, to June 30, 2020, and the blood sample collection covers the first half of 2020 when COVID-19 emerged and spread. The number of patients or hospital admission rates might be reflected on the changes in the amounts of samples sent to our laboratories. Blood samples collected in the five ICUs of PKUFH in 2020 were decreased, relative to the first half of the other 3 years. However, the amount of blood specimens of Miyun ICU did not change much. The possible reason is that many patients from other cities would come to Peking University First Hospital for treatment before the outbreak of COVID-19, but fewer people came from other areas due to the prevention and control of the epidemic thereafter. The patient population of Miyun Teaching Hospital is mainly located in the suburban; thus, the amount of specimens does not change significantly. These two hospitals are not designated as medical institutions for treatment of COVID-19 patients (all of the COVID-19 patients in Beijing were hospitalized to Beijing Ditan Hospital). All the patients admitted are not infectious with SARS-CoV-2, and no nosocomial infection related to COVID-19 happened in the hospitals. Therefore, effects of COVID-19 infection on patients with BSIs are not considered in the present study.

The distribution of microorganisms isolated from blood specimens showed that the total proportions of Gram-positive bacteria in the PICU, SICU, CICU, GICU, and Miyun ICU were all much higher than Gram-negative bacterial strains. Among these positive blood cultures, several frequently isolated pathogens were S. hominis, S. epidermidis, and S. capitis which belong to coagulase-negative staphylococci (CoNS). In recent years, CoNS have become true pathogens, rather than simply culture contaminants, causing BSIs and cardiovascular infections among other conditions (Yamada et al., 2017). Another research also reported a similar finding that CoNS were the common causative agents of BSI in European populations (Huttunen et al., 2015). Moreover, Enterococcus spp. (such as E. faecalis and E. faecium) was one of the prevalent organisms in the PICU, SICU, GICU, and Miyun ICU, and S. aureus was the second most frequent bacterium in CICU, which might indicate that skin, soft tissue, bone, and joint sources of infection caused BSI by Gram-positive cocci such as S. aureus, enterococci, and streptococci. In the PICU, the major bacterium was Gram-negative A. baumannii, followed by S. epidermidis and E. faecalis. However, Singhi et al. (2008) from India and Maham et al. (2018) from Iran observed Gram-negative bacteria as the predominant isolates of pediatric BSIs, common being K. pneumoniae (20.1% and 8.8%) and Acinetobacter spp. (8.6% and 7.9%). The difference between our research and theirs may be due to the distinct social, economic, and environmental factors in these regions. K. pneumoniae was the most frequent pathogen in three of the six ICUs (the SICU, CICU, and RICU), consistent with a recent review showing that Klebsiella spp., the second (behind E. coli) overall cause of Gram-negative BSIs, have been and remain one of key pathogens from high-income countries (Kern and Rieg, 2020). In the GICU, the dominant microorganism was E. coli which was also reported as the most prevalent pathogen by a previous research based on the Swiss ANRESIS, revealing that the incidence of BSIs increased throughout the study period 2008–2014, especially among geriatric patients (Buetti et al., 2017). In the Miyun ICU, the most common isolates of blood samples were S. epidermidis (the frequency was 18.18%, much higher than other ICUs), which might be partly due to sample or culture contaminants, and thus, it is suggested to standardize specimen collection for patients’ blood culture in this suburban hospital. It is worth noting that the RICU was the only ICU where Gram-negative bacteria remained the key microorganisms involved in BSIs because Enterobacteriaceae spp. (such as K. pneumoniae) might be the predominant microorganisms in respiratory tract infection patients (Mahendra et al., 2018; Duan et al., 2020). A 3-year multicenter retrospective study showed that individuals aged 0–5 years and ≥40 years were the main demographics at risk of infection by E. coli, K. pneumoniae, and A. baumannii, while individuals aged 0–5 years were the major demographic at risk of infection by S. aureus, E. faecalis, E. faecium, etc (Tian et al., 2018). According to our study, there was also a high divergence between pediatric and geriatric patients, or among different ICUs.

In the hospital setting, intensive and prolonged use of antimicrobial drugs introduces the emergence and spread of highly antibiotic-resistant infections (Prestinaci et al., 2015). Currently, antimicrobial resistance is one of the most serious global public health threats which call for action from all of society. In order to achieve appropriate therapeutics, an updated epidemiology of antimicrobial sensitivity is required to support therapeutic guidelines. In the present study, we observed that S. hominis of BSIs remained highly susceptible (>70%) to gentamicin, linezolid, daptomycin, teicoplanin, vancomycin, tigecycline, and rifampicin in all the ICUs. Its antibiotic sensitivity to levofloxacin was moderate in the PICU and CICU, but mild (<30%) in the SICU, RICU, and GICU. Moreover, MRCNS was one of the major resistance patterns of positive isolates from the ICUs in this study, and a 4-year retrospective survey in a Japanese tertiary hospital revealed that MRCNS bacteremia (diagnosed as two or more positive blood cultures on the same day with clinical signs of infection) was associated with a low mortality rate and suggested that glycopeptides, especially teicoplanin, must be used appropriately to prevent antibiotic resistance in MRCNS (Yamada et al., 2017). It is vital to treat staphylococcus infections as the increasing proportion of CoNS isolates presented as methicillin-resistant. E. faecium exhibited high susceptibility to linezolid and tigecycline in all the ICUs, and it was highly susceptible to teicoplanin and vancomycin in the PICU, SICU, and Miyun ICU. A meta-analysis revealed that the prevalence of vancomycin-resistant Enterococcus (VRE) infections in Iran was 9.4% among culture-positive cases for Enterococcus spp., and analyzed the prevalence of multidrug-resistant VRE in developed countries, such as Germany (11.2%), the United Kingdom (8.5–12.5%), and Italy (9%) (Emaneini et al., 2016). Olivier et al. (2008) observed that of the 768 patients colonized with VRE, 4.0% usually developed VRE BSIs due to a related strain; therefore, continuously monitoring trends in the microbiology of BSI pathogens is very important. In general, for both S. hominis and E. faecium isolated from BSIs, RICU and GICU exhibited more serious antibiotic resistance than other ICUs in our study. In addition, the antibiotic-resistant pathogens of BSIs in Peking University First Hospital were generally more than that in Miyun Teaching Hospital. The phenomenon might result from the complexity of the hospitalized patient’s illness and inappropriate use of antimicrobials in primary hospitals or secondary hospitals as the multidrug-resistant bacteria emerged before the submission into tertiary hospitals which then prescribed more broad-spectrum antibiotics in tertiary hospital. As a predominant Gram-negative bacterium in blood cultures, K. pneumoniae was highly susceptible to doxycycline, minocycline, and tigecycline in all the ICUs except RICU, and its antibiotic sensitivity to imipenem, meropenem, amikacin, ciprofloxacin, and levofloxacin in the GICU was high or moderate in the PICU, CICU, and GICU, but mild in the SICU and RICU. K. pneumoniae is a common cause of healthcare- and ICU-acquired infections, and one of the key pathogens from bacterial BSIs (Kern and Rieg, 2020). Increasingly used carbapenem has contributed significantly to the emergence and rapid dissemination of carbapenem-resistant K. pneumoniae (CRKP) strains (Landman et al., 2007; Girometti et al., 2014). Moreover, carbapenem-resistant Enterobacteriaceae (CRE) [including CRKP, carbapenem-resistant Pseudomonas aeruginosa (CRPA), etc] was one of the major antibiotic resistance types in RICU, SICU, and CICU. The multidrug-resistance patterns such as CRE and carbapenem-resistant A. baumannii (CRAB) have been increasing in recent years. In the ICUs of our research, A. baumannii only exhibited high susceptibility to tigecycline and mild sensitivity to imipenem and meropenem. Its susceptibility to ceftazidime, cefepime, tobramycin, levofloxacin, doxycycline, and minocycline was moderate in the PICU, but mild in the SICU and RICU. Moreover, CRAB was one of the common multidrug-resistance patterns in the PICU. Liu et al. (2020) conducted a prospective multicenter study in China and suggested that carbapenem resistance has a significant impact on mortality for patients with A. baumannii complex BSI. E. coli was highly susceptible to the tested antibiotics in the CICU, whereas it exhibited moderate or relatively low drug susceptibility to the antibiotics (except doxycycline, minocycline, and tigecycline) in the PICU, SICU, and GICU. In our study, for K. pneumoniae, A. baumannii, and E. coli isolated from BSIs, RICU, SICU, and GICU exhibited more serious antibiotic resistance than other ICUs. The phenomenon may result from inappropriate empirical use of antimicrobials for patients with respiratory tract infections or to avoid suspected infection of surgical operations. Furthermore, age is probably a main contributor to the multidrug-resistant bacteria emerged among the geriatric patients undergoing prolonged treatments with broad-spectrum antibiotics.

In this study, the blood cultures were obtained from several different ICUs (including pediatric, adult, or elderly patients) in one urban and one outer suburban hospital. The sample size of this dual-center retrospective study from 2017 to 2020 was relatively large. Therefore, the bacterial distributions and microbial susceptibility patterns analyzed in various ICUs and distinct age groups were relatively solid. However, our research has certain limitations, partly because it was only focused on BSIs from one tertiary hospital and outer suburban hospital in Beijing, which might have led to enrollment bias considering the geographic location.

Conclusion

The distribution of prevalent microorganisms and their antibiotic susceptibility revealed a high divergence among BSIs in different ICUs from a tertiary hospital and outer suburban hospital. RICU and GICU exhibited more serious antibiotic resistance than other ICUs. Therefore, different antibiotic therapies for various wards and distinct age groups were suggested, further strengthening the importance of active prevention and control strategies for the emergence and spread of highly antibiotic-resistant infections.

Data Availability Statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.

Ethics Statement

The studies involving human participants were reviewed and approved by the Peking University First Hospital and Miyun Teaching Hospital of Capital Medical University. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.

Author Contributions

ND designed the study, carried out the data collection, drafted the initial manuscript, and reviewed and revised the manuscript. LS carried out the data collection and reviewed and revised the manuscript. CH coordinated the data collection and reviewed the manuscript. HL designed the study and critically reviewed the manuscript for important intellectual content. BC reviewed the manuscript for important intellectual content. All authors have read and approved the manuscript.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Abbreviations

BSI, bloodstream infection; ICUs, intensive care units; PICU, pediatric ICU; SICU, surgical ICU; CICU, cardiac ICU; RICU, respiratory ICU; GICU, geriatric ICU; ANRESIS, antibiotic resistance surveillance system; SOP, standard operation procedure; K–B, Kirby–Bauer; CLSI, Clinical Laboratory Standards Institute; ESBL, extended-spectrum β -lactamase; CRE, carbapenem-resistant Enterobacteriaceae; CRAB, carbapenem-resistant Acinetobacter baumannii; MRSA, methicillin-resistant Staphylococcus aureus; MRCNS, methicillin-resistant coagulase-negative Staphylococcus; VRE, vancomycin-resistant Enterococcus; SIRS, systemic inflammatory response syndrome; CoNS, coagulase-negative staphylococci.

References

Agarwal, R., Gupta, D., Ray, P., Aggarwal, A. N., and Jindal, S. K. (2006). Epidemiology, risk factors and outcome of nosocomial infections in a respiratory intensive care unit in North India. J. Infect. 53, 98–105. doi: 10.1016/j.jinf.2005.10.021

PubMed Abstract | CrossRef Full Text | Google Scholar

Buetti, N., Atkinson, A., Marschall, J., and Kronenberg, A. (2017). Incidence of bloodstream infections: a nationwide surveillance of acute care hospitals in Switzerland 2008-2014. BMJ Open 7:e013665. doi: 10.1136/bmjopen-2016-013665

PubMed Abstract | CrossRef Full Text | Google Scholar

Deen, J., von Seidlein, L., Andersen, F., Elle, N., White, N. J., and Lubell, Y. (2012). Community-acquired bacterial bloodstream infections in developing countries in south and southeast Asia: a systematic review. Lancet Infect. Dis. 12, 480–487. doi: 10.1016/S1473-3099(12)70028-2

CrossRef Full Text | Google Scholar

Del Bono, V., and Giacobbe, D. R. (2016). Bloodstream infections in internal medicine. Virulence 7, 353–365. doi: 10.1080/21505594.2016.1140296

PubMed Abstract | CrossRef Full Text | Google Scholar

Droz, N., Hsia, Y., Ellis, S., Dramowski, A., Sharland, M., and Basmaci, R. (2019). Bacterial pathogens and resistance causing community acquired paediatric bloodstream infections in low- and middle-income countries: a systematic review and meta-analysis. Antimicrob. Resist. Infect. Control 8:207. doi: 10.1186/s13756-019-0673-5

PubMed Abstract | CrossRef Full Text | Google Scholar

Duan, N., Du, J., Huang, C., and Li, H. (2020). Microbial distribution and antibiotic susceptibility of lower respiratory tract infections patients from pediatric ward, adult respiratory ward, and respiratory intensive care unit. Front. Microbiol. 11:1480. doi: 10.3389/fmicb.2020.01480

CrossRef Full Text | Google Scholar

Emaneini, M., Hosseinkhani, F., Jabalameli, F., Nasiri, M. J., Dadashi, M., Pouriran, R., et al. (2016). Prevalence of vancomycin-resistant Enterococcus in Iran: a systematic review and meta-analysis. Eur. J. Clin. Microbiol. Infect. Dis. 35, 1387–1392. doi: 10.1007/s10096-016-2702-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Girometti, N., Lewis, R. E., Giannella, M., Ambretti, S., Bartoletti, M., Tedeschi, S., et al. (2014). Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapy. Medicine 93, 298–309. doi: 10.1097/MD.0000000000000111

PubMed Abstract | CrossRef Full Text | Google Scholar

Goto, M., and Al-Hasan, M. N. (2013). Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin. Microbiol. Infect. 19, 501–509. doi: 10.1111/1469-0691.12195

PubMed Abstract | CrossRef Full Text | Google Scholar

Huttunen, R., Attman, E., Aittoniemi, J., Outinen, T., Syrjanen, J., Karki, T., et al. (2015). Nosocomial bloodstream infections in a Finnish tertiary care hospital: a retrospective cohort study of 2175 episodes during the years 1999-2001 and 2005-2010. Infect. Dis. (Lond.). 47, 20–26. doi: 10.3109/00365548.2014.956791

PubMed Abstract | CrossRef Full Text | Google Scholar

Kern, W. V., and Rieg, S. (2020). Burden of bacterial bloodstream infection-a brief update on epidemiology and significance of multidrug-resistant pathogens. Clin. Microbiol. Infect. 26, 151–157. doi: 10.1016/j.cmi.2019.10.031

PubMed Abstract | CrossRef Full Text | Google Scholar

Labi, A. K., Obeng-Nkrumah, N., Bjerrum, S., Enweronu-Laryea, C., and Newman, M. J. (2016). Neonatal bloodstream infections in a Ghanaian tertiary hospital: are the current antibiotic recommendations adequate? BMC Infect. Dis. 16:598. doi: 10.1186/s12879-016-1913-4

PubMed Abstract | CrossRef Full Text | Google Scholar

Landman, D., Bratu, S., Kochar, S., Panwar, M., Trehan, M., Doymaz, M., et al. (2007). Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. J. Antimicrob. Chemother. 60, 78–82. doi: 10.1093/jac/dkm129

PubMed Abstract | CrossRef Full Text | Google Scholar

Le Doare, K., Bielicki, J., Heath, P. T., and Sharland, M. (2015). Systematic review of antibiotic resistance rates among gram-negative bacteria in children with sepsis in resource-limited countries. J. Pediatr. Infect. Dis. Soc. 4, 11–20. doi: 10.1093/jpids/piu014

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, Y., Wang, Q., Zhao, C., Chen, H., Li, H., Wang, H., et al. (2020). Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in Acinetobacter baumannii complex bacteraemia: experience from the Chinese antimicrobial resistance surveillance of nosocomial infections (CARES) network. J. Med. Microbiol. 69, 949–959. doi: 10.1099/jmm.0.001222

PubMed Abstract | CrossRef Full Text | Google Scholar

Maham, S., Fallah, F., Gholinejad, Z., Seifi, A., and Hoseini-Alfatemi, S. M. (2018). Bacterial etiology and antibiotic resistance pattern of pediatric bloodstream infections: a multicenter based study in Tehran, Iran. Ann. Ig. 30, 337–345.

Google Scholar

Mahendra, M., Jayaraj, B. S., Lokesh, K. S., Chaya, S. K., Veerapaneni, V. V., Limaye, S., et al. (2018). Antibiotic prescription, organisms and its resistance pattern in patients admitted to respiratory ICU with respiratory infection in Mysuru. Indian J. Crit. Care Med. 22, 223–230. doi: 10.4103/ijccm.IJCCM_409_17

PubMed Abstract | CrossRef Full Text | Google Scholar

Olivier, C. N., Blake, R. K., Steed, L. L., and Salgado, C. D. (2008). Risk of vancomycin-resistant enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect. Control Hosp. Epidemiol. 29, 404–409.

Google Scholar

Penno, E. C., Baird, S. J., and Crump, J. A. (2015). Cost-Effectiveness of surveillance for bloodstream infections for sepsis management in low-resource settings. Am. J. Trop. Med. Hyg. 93, 850–860.

Google Scholar

Prestinaci, F., Pezzotti, P., and Pantosti, A. (2015). Antimicrobial resistance: a global multifaceted phenomenon. Pathog. Glob. Health 109, 309–318. doi: 10.1179/2047773215y.0000000030

PubMed Abstract | CrossRef Full Text | Google Scholar

Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., et al. (2017). Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 43, 304–377.

Google Scholar

Singhi, S., Ray, P., Mathew, J. L., and Jayashree, M. (2008). Nosocomial bloodstream infection in a pediatric intensive care unit. Indian J. Pediatr. 75, 25–30. doi: 10.1007/s12098-008-0002-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Tian, L., Sun, Z., and Zhang, Z. (2018). Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective study. BMC Public Health 18:1121. doi: 10.1186/s12889-018-6013-5

PubMed Abstract | CrossRef Full Text | Google Scholar

Watson, C. M., and Al-Hasan, M. N. (2014). Bloodstream infections and central line-associated bloodstream infections. Surg. Clin. North Am. 94, 1233–1244.

Google Scholar

World Health Organization. (2014). Antimicrobial Resistance: Global Report on Surveillance 2014. Geneva: WHO.

Google Scholar

Yamada, K., Namikawa, H., Fujimoto, H., Nakaie, K., Takizawa, E., Okada, Y., et al. (2017). Clinical characteristics of methicillin-resistant coagulase-negative staphylococcal bacteremia in a tertiary hospital. Intern. Med. 56, 781–785. doi: 10.2169/internalmedicine.56.7715

PubMed Abstract | CrossRef Full Text | Google Scholar